Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-12

Clinical Trial Update: Chronic Lymphocytic Leukemia Responds to Dermal Chelation [NA]

View source ↗

Summary

Clinical trial update reports that Chronic Lymphocytic Leukemia responds to dermal chelation therapy; the available details are limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dermal Chelation

Snippet

Sponsor: Optimum Health, Natural Healthcare Center | Conditions: Chronic Lymphocytic Leukemia | NA | Status: UNKNOWN